NEW BRUNSWICK, N.J., Oct. 25, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 26th Annual Credit Suisse Health Care Conference on Wednesday, Nov. 8, at The Phoenician in Scottsdale, AZ.  Vanessa Broadhurst, President, Cardiovascular & Metabolism, Janssen Pharmaceuticals and Scott White, President, Immunology, Janssen Pharmaceuticals will represent the Company in a session scheduled at 9:50 a.m. (Mountain Standard Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

View original content with multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-26th-annual-credit-suisse-health-care-conference-300543170.html

SOURCE Johnson & Johnson